TopFunds

Zimmer Biomet

NYSE: ZBH

Stock price

95.33 USD

(+0%) TODAY

Health Care EquipmentMedical - Devices
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
0.3
1.5
9
(1.9)
5.5
(0.7)
1.9
1.1
4.9
4.4
3.6
29.9%
02Free cash flow per share
3.6
7.2
7
7.8
5.7
5.3
6.4
5.1
5.7
5.6
7.4
7.5%
03Dividends per share
0.9
0.9
0.9
0.9
0.9
0.9
0.9
1
1
1
1
1.2%
04Dividends payout, %
1.1%
61.6%
10.7%
(51.5)%
17.4%
(1.4)%
49.8%
87%
19.6%
21.7%
27%
38.1%
PROFIT AND LOSS STATEMENT
05Revenue
$ 5,998
$ 7,668
$ 7,803
$ 7,933
$ 7,982
$ 6,128
$ 6,827
$ 6,940
$ 7,394
$ 7,679
$ 8,232
3.2%
06% Change
-
27.9%
1.8%
1.7%
0.6%
(23.2)%
11.4%
1.7%
6.6%
3.9%
7.2%
3.2%
07Cost of revenue
(1,801)
(2,382)
(2,133)
(2,272)
(2,253)
(1,824)
(1,960)
(2,020)
(2,084)
(2,191)
(3,160)
5.8%
08Gross profit
4,197
5,287
5,670
5,661
5,730
4,303
4,867
4,920
5,310
5,487
5,072
1.9%
09% Margin
70%
68.9%
72.7%
71.4%
71.8%
70.2%
71.3%
70.9%
71.8%
71.5%
61.6%
70.2% A
10Operating expenses
(3,730)
(4,466)
(4,871)
(5,627)
(4,592)
(4,220)
(4,007)
(4,224)
(4,033)
(4,202)
(3,710)
(0.1)%
11% of Revenue
(62.2)%
(58.2)%
(62.4)%
(70.9)%
(57.5)%
(68.9)%
(58.7)%
(60.9)%
(54.5)%
(54.7)%
(45.1)%
(59.5)% A
12Operating Income
467.3
821.1
799.3
33.8
1,138
83.1
860.3
696.3
1,278
1,286
1,362
11.3%
13Income tax expense
(7)
(95)
(1,349)
(108.2)
(225.7)
(96)
(53.5)
(112.3)
(42.2)
(131.4)
(125.7)
33.5%
14Net Income
147
305.9
1,814
(379.2)
1,132
(138.9)
401.6
231.4
1,024
903.8
705.2
17%
15% Margin
2.5%
4%
23.2%
(4.8)%
14.2%
(2.3)%
5.9%
3.3%
13.9%
11.8%
8.6%
7.3% A
16Shares Outstanding
189,800
202,400
203,700
203,500
206,700
207,000
210,400
210,300
209,700
203,900
198,700
0.5%
17EPS Basic
0.3
1.5
9.1
(1.9)
5.5
(0.7)
1.9
1.1
4.9
4.5
3.6
29.4%
18EPS Diluted
0.3
1.5
9
(1.9)
5.5
(0.7)
1.9
1.1
4.9
4.4
3.6
29.9%
19EBITDA
1,152
1,794
1,853
1,059
2,139
1,005
1,645
1,495
2,220
2,251
2,217
6.8%
% Margin
19.2%
23.4%
23.7%
13.4%
26.8%
16.4%
24.1%
21.5%
30%
29.3%
26.9%
23.2% A
20Net Interest Income (expense)
(277.2)
(355)
(325.3)
(289.3)
(226.9)
(212.1)
(208.4)
(164.8)
(201.2)
(218)
(292.8)
0.6%
21Net Debt / EBITDA
8.7
5.9
5.2
7.9
3.6
7.3
4.1
3.6
2.4
2.5
3.1
4.9 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
1,459
634.1
524.4
542.8
617.9
802.1
378.1
375.7
415.8
525.5
591.9
(8.6)%
23Short-term investments
164.6
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
1,447
1,604
1,544
1,276
1,364
1,453
1,260
1,382
1,442
1,481
1,704
1.7%
25Other current assets
529.2
465.7
428
352.3
357.1
377.8
1,099
522.9
366.1
430
537.2
0.2%
26Inventory
2,254
1,969
2,082
2,257
2,385
2,451
2,148
2,147
2,385
2,235
2,286
0.1%
27Total Current Assets
5,854
4,674
4,582
4,427
4,724
5,083
4,885
4,427
4,610
4,672
5,120
(1.3)%
Non-Current Assets
28Net property, plant & equipment
2,063
2,038
2,039
2,015
2,077
2,048
1,837
1,873
2,060
2,049
2,207
0.7%
29Long-term investments
-
-
-
-
-
-
27.6
16.6
31.6
73.2
39.4
-
30Other non-current assets
19,244
19,983
19,411
17,684
17,837
17,287
16,707
14,750
14,795
14,572
15,725
(2)%
31Total Non-Current Assets
21,307
22,021
21,449
19,699
19,915
19,334
18,571
16,639
16,887
16,694
17,972
(1.7)%
Total Assets
27,161
26,684
26,014
24,127
24,639
24,418
23,456
21,066
21,497
21,365
23,092
(1.6)%
LIABILITIES
Current Liabilities
32Accounts payable
284.8
364.5
330.2
362.6
400.9
330
306.5
354.1
410.6
194.6
303
0.6%
33Short-term debt
-
575.6
1,225
525
1,500
500
1,605
544.3
900
863
587.1
-
34Other current liabilities
1,333
1,441
1,515
1,534
1,541
1,727
1,556
1,460
1,547
1,393
1,694
2.4%
35Total Current Liabilities
1,618
2,382
3,070
2,421
3,442
2,557
3,468
2,358
2,857
2,451
2,584
4.8%
Non-Current Liabilities
36Long-term debt
11,497
10,666
8,918
8,414
6,721
7,627
5,464
5,152
4,868
5,342
6,932
(4.9)%
37Other non-current liabilities
4,156
3,967
2,291
2,016
2,083
2,035
1,858
1,529
1,284
1,097
870.2
(14.5)%
38Total Non-Current Liabilities
15,653
14,633
11,209
10,429
8,804
9,661
7,322
6,681
6,151
6,438
7,802
(6.7)%
39Total Liabilities
17,271
17,015
14,279
12,851
12,246
12,218
10,790
9,039
9,009
8,889
10,386
(5)%
SHAREHOLDERS` EQUITY
40Common stock
3
3.1
3.1
3.1
3.1
3.1
3.1
3.1
3.2
3.2
3.2
0.7%
41Retained earnings / (deficit)
8,348
8,467
10,023
9,491
10,427
10,087
10,292
9,559
10,385
11,095
11,611
3.4%
42Accumulated other comprehensive income / (loss)
(329)
(434)
(83.2)
(187.4)
(241.9)
(297.8)
(231.6)
(179.3)
(191)
(262.8)
(205.7)
(4.6)%
43Noncontrolling interests
1.5
1
(0.3)
4.8
4.7
5.2
5.7
6.7
7.7
8.1
8.1
18.4%
44Total shareholders' equity
9,889
9,670
11,736
11,276
12,393
12,199
12,666
12,027
12,481
12,476
12,706
2.5%
45Total Liabilities and shareholders' Equity
27,161
26,684
26,014
24,127
24,639
24,418
23,456
21,066
21,489
21,365
23,092
(1.6)%
46Total Debt
11,497
11,241
10,143
8,939
8,221
8,127
7,069
5,697
5,768
6,205
7,519
(4.2)%
47Net Debt
10,038
10,607
9,618
8,396
7,604
7,324
6,691
5,321
5,352
5,679
6,927
(3.6)%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
147
305.9
1,814
(379.2)
1,132
(138.9)
401.6
231.4
1,024
903.8
705.2
17%
49Depreciation & amortization
712.4
1,039
1,063
1,041
1,006
898.4
937.7
926.4
951.7
996.3
1,094
4.4%
50Share-based compensation expense
46.4
57.3
53.7
65.5
84.3
73.8
76
105
99.8
101
90.2
6.9%
51Changes in working capital and other assets
(56)
229.7
(1,348)
1,021
(636.2)
371.2
83.9
21.9
(493.9)
(501.7)
(192.1)
13.1%
52Net cash flows from operating activities
849.8
1,632
1,582
1,747
1,586
1,205
1,499
1,285
1,582
1,499
1,697
7.2%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(167.7)
(184.7)
(156)
(162.7)
(207.1)
(111.9)
(143.6)
(187.9)
(291.1)
(203.8)
(224.5)
3%
54Purchases of investments / marketable securities
(481.2)
(347)
(337)
(276.3)
(315.9)
(259)
(273.6)
(258.3)
(311.7)
(240.3)
(300.5)
(4.6)%
55Proceeds from maturities of marketable securities
802.9
286.2
-
69.2
48.1
53.5
1.9
89.4
33.4
22.1
-
-
56Other investing activities
(7,712)
(1,446)
(17.8)
(46.8)
(254.4)
(296.4)
(88.3)
(172.4)
(209.5)
(466.1)
(1,451)
(15.4)%
57Net cash flows from investing activities
(7,558)
(1,692)
(510.8)
(416.6)
(729.3)
(613.8)
(503.6)
(529.2)
(778.9)
(888.1)
(1,976)
(12.6)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(150)
(415.5)
-
-
-
-
122.5
(126.4)
(692.2)
(868)
(447.3)
11.6%
59Dividends paid, net
(157.1)
(188.4)
(193.6)
(195.2)
(196.7)
(198.5)
(200.1)
(201.2)
(200.9)
(196)
(190.3)
1.9%
60Debt issuance (repayments), net
7,366
(259.6)
(1,248)
(1,154)
(716.1)
(252.9)
(1,055)
(1,061)
54.6
536.3
1,029
(17.9)%
61Other financing activities
80.6
120.3
231.3
47.4
132.9
29.6
(173.4)
544.5
75
43.2
(65.5)
-
62Net cash flows from financing activities
7,140
(743.2)
(1,211)
(1,302)
(779.9)
(421.8)
(1,306)
(843.8)
(763.5)
(484.5)
326
(26.6)%
63Increase (decrease) in cash and cash equivalents
369.3
(825.2)
(109.7)
18.4
75.1
184.2
(323.6)
(102.8)
40.1
109.7
66.4
(15.8)%
64Cash and equivalents, ending balance
1,453
634.1
524.4
542.8
617.9
802.1
478.5
375.7
415.8
525.5
591.9
(8.6)%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
682.1
1,448
1,426
1,585
1,379
1,093
1,356
1,097
1,291
1,296
1,473
8%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Zimmer Biomet (ZBH) financial statements and performance

Explore Zimmer Biomet (ZBH) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.